Arteriosclerosis, Vol 7, 620-626, Copyright © 1987 by American Heart Association
ARTICLES |
JC Russell, SK Ahuja, V Manickavel, RV Rajotte and RM Amy
Department of Surgery, University of Alberta, Edmonton, Canada.
The LA/N-cp rat is, when homozygous for the cp gene, hyperphagous, hyperlipidemic, and corpulent. The corpulent males develop atherosclerotic disease and myocardial lesions while corpulent females and lean rats do not. The fasting plasma glucose concentrations of corpulent rats are in the normal range, but insulin concentrations are mildly elevated in corpulent females and markedly elevated in corpulent males. Glucose tolerance testing reveals a glucose intolerance in corpulent rats in the presence of very high insulin concentrations, and this deficiency is more severe in the male rats. Glucagon concentrations are higher in corpulent rats than lean rats at 3 months of age and decrease progressively with age. In contrast, glucagon concentrations increase with age in lean rats and are higher than those in corpulent rats at 9 months. The islets of Langerhans of corpulent rats exhibit marked hyperplasia that increases with age. The hyperplasia is less extreme in corpulent female rats. The abnormalities suggest that this strain of rats has an insulin resistance leading to impaired glucose tolerance and progressive pancreatic disturbance. This process may be related to an accompanying defect causing elevated concentrations of very low density lipoproteins and correlates with the development of atherosclerotic disease.
This article has been cited by other articles:
![]() |
D. Shi, M. K. Dyck, R. R. E. Uwiera, J. C. Russell, S. D. Proctor, and D. F. Vine A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome Endocrinology, September 1, 2009; 150(9): 4425 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Lu, M. R. Ruth, S. D. Goruk, M. J. Reaney, D. R. Glimm, D. F. Vine, C. J. Field, and S. D. Proctor Trans-11 Vaccenic Acid Dietary Supplementation Induces Hypolipidemic Effects in JCR:LA-cp Rats J. Nutr., November 1, 2008; 138(11): 2117 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats J. Nutr., February 1, 2006; 136(2): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-y. Qiao, R. Zhande, T. L. Jetton, G. Zhou, and X. J. Sun In Vivo Phosphorylation of Insulin Receptor Substrate 1 at Serine 789 by a Novel Serine Kinase in Insulin-resistant Rodents J. Biol. Chem., July 12, 2002; 277(29): 26530 - 26539. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats J. Nutr., June 1, 2002; 132(6): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Velliquette, R. J. Koletsky, and P. Ernsberger Plasma Glucagon and Free Fatty Acid Responses to a Glucose Load in the Obese Spontaneous Hypertensive Rat (SHROB) Model of Metabolic Syndrome X Experimental Biology and Medicine, March 1, 2002; 227(3): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Misra, J. S. C. Gilchrist, J. C. Russell, and G. N. Pierce Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1811 - H1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-y. Qiao, J. L. Goldberg, J. C. Russell, and X. J. Sun Identification of Enhanced Serine Kinase Activity in Insulin Resistance J. Biol. Chem., April 9, 1999; 274(15): 10625 - 10632. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamakawa, S.-i. Tanaka, K. Tamura, F. Isoda, K. Ukawa, Y. Yamakura, Y. Takanashi, Y. Kiuchi, S. Umemura, M. Ishii, et al. Wistar Fatty Rat Is Obese and Spontaneously Hypertensive Hypertension, January 1, 1995; 25(1): 146 - 150. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |